604/604
articles
604/604
articles
|
Sort by:
October 12, 2026
A multicentre Australian study tests Us2.ai's echocardiographic interpretation against expert ED sonologists, revealing agreement rates, yield gaps, and scope limits relevant to clinical deployment.
+2 more
October 12, 2026
Lunit INSIGHT CXR raises detection sensitivity for less-experienced radiologists reading chest X-rays, though radiology directors should note a trade-off in specificity.
+2 more
October 8, 2026
Us2.ai's automated echocardiography shows repeatability comparable to experienced cardiologists in ATTR-CM, though expert oversight remains essential for advanced disease monitoring.
+2 more
October 8, 2026
AI detected far more pathologically sampled lymph node stations than routine radiology reports, signalling a major efficiency gain for systematic nodal assessment in lung cancer CT workups.
+2 more
October 8, 2026
New research in Radiology: Imaging Cancer compares Transpara AI detection against short-term breast cancer risk models, both within and beyond intended screening use.
+2 more
October 8, 2026
Transpara AI shows potential to support risk stratification of single-view asymmetries in screening mammography, with low malignancy yield among non-AI-flagged cases.
+2 more
October 8, 2026
A prospective study examines whether AI-assisted fracture detection during out-of-hours paediatric emergency care reduces diagnostic revisions and patient recall rates.
+1 more
October 8, 2026
A study in Diagnostics compares SubtleMR deep-learning MRI reconstruction against conventional knee MRI sequences in patients presenting with knee pain.
+2 more
October 8, 2026
Study finds ProFound AI's tomosynthesis and synthesized-2D scores differ within individual breasts, warning against using a low AI score alone to downgrade suspicious findings.
+2 more
October 8, 2026
New research in J. Clinical Medicine evaluates iCAD's ProFound AI Risk for predicting subsequent breast cancer in women with a prior breast cancer history.
+2 more
October 2, 2026
New on Health AI Register: Vara Tomosynthesis by Vara (MX Healthcare GmbH) an application that analyses digital breast tomosynthesis examinations in breast cancer screening.New on Health AI Register:...
